Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Enrollment did not progress as anticipated
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to test a new amplified stethoscope(AudioDoc) that can detect the presence of bruit by using an acoustic signal to represent the bruit. This pilot study will address two questions: is there a detectable difference in recorded sound signal of carotid and femoral bruit when compared to sound signals captured when there is no bruit present; is the use of a visual recorded signal more accurate in identifying carotid and femoral bruit when compared to traditional auscultation with a regular stethoscope and ultrasound.
Recorded signals are stored on a laptop computer. The signals later undergo Fourier analysis are then compared to the findings on carotid ultrasoud as to degree of stenosis. Subjects with high grade stenosis in which no bruit was ascultated but in which carotid ultrasound data suggests a bruit may be present are studied for soft /inaudible bruits. When available, data will be correlated to CT/conventional angiographic studies.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| adults | adults audiodoc use to evaluate for carotid or femoral bruit |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| AudioDoc | Device | AudioDoc will be used to identify the carotid and femoral bruit |
|
| Measure | Description | Time Frame |
|---|---|---|
| Comparison of bruit signal obtained from the amplified stethoscope(AudioDoc) to that found by conventional ultrasonography. | subjects will be followed for duration of hospital stay, typically four days. |
| Measure | Description | Time Frame |
|---|---|---|
| To assess the frequency spectral differences obtained from the different recording modalities | duration of hospital stay, typically four days |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
any person age 19 through 90 years who have been clinically determined to require evaluation of carotid or femoral arteries for suspected stenosis
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jonathan Dissin, MD | Albert Einstein Healthcare Network | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Albert Einstein Healthcare Network | Philadelphia | Pennsylvania | 19141 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D016893 | Carotid Stenosis |
| ID | Term |
|---|---|
| D002340 | Carotid Artery Diseases |
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D009422 | Nervous System Diseases |
| D001157 | Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |